这是一篇来自已证抗体库的有关人类 CD48的综述,是根据12篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD48 抗体。
CD48 同义词: BCM1; BLAST; BLAST1; MEM-102; SLAMF2; hCD48; mCD48

BioLegend
小鼠 单克隆(BJ40)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD48抗体(BioLegend, 336707)被用于被用于流式细胞仪在人类样本上 (图 s3). Stem Cell Reports (2020) ncbi
小鼠 单克隆(BJ40)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD48抗体(BioLegend, BJ40)被用于被用于流式细胞仪在人类样本上 (图 1b). BMC Immunol (2019) ncbi
小鼠 单克隆(BJ40)
  • mass cytometry; 人类; 图 s3a
BioLegend CD48抗体(BioLegend, BL40)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(BJ40)
  • 流式细胞仪; 人类; 图 e6b
  • 流式细胞仪; 小鼠; 图 e3a
BioLegend CD48抗体(Biolegend, BJ40)被用于被用于流式细胞仪在人类样本上 (图 e6b) 和 被用于流式细胞仪在小鼠样本上 (图 e3a). Nature (2017) ncbi
小鼠 单克隆(BJ40)
  • 流式细胞仪; 人类; 图 1d
BioLegend CD48抗体(biolegend, BJ40)被用于被用于流式细胞仪在人类样本上 (图 1d). Oncotarget (2016) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(J4.57)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD48抗体(Beckman Coulter, J4-57)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(J4.57)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD48抗体(Beckman, J4-57)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
碧迪BD
小鼠 单克隆(TÜ145)
  • 流式细胞仪; 人类; 图 2i, s6g
碧迪BD CD48抗体(BD Biosciences, TU145)被用于被用于流式细胞仪在人类样本上 (图 2i, s6g). Nat Commun (2022) ncbi
小鼠 单克隆(TÜ145)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD48抗体(BD Biosciences, TU145)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(TÜ145)
  • 流式细胞仪; 人类; 图 s3a
碧迪BD CD48抗体(BD Bioscience, TU145)被用于被用于流式细胞仪在人类样本上 (图 s3a). Nat Commun (2016) ncbi
小鼠 单克隆(TÜ145)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD48抗体(BD, 552855)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(TÜ145)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD48抗体(BD Biosciences, TU145)被用于被用于流式细胞仪在人类样本上 (图 1e). Cytotherapy (2015) ncbi
文章列表
  1. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed 出版商
  2. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed 出版商
  3. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed 出版商
  4. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  5. Chen J, Zhong M, Guo H, Davidson D, Mishel S, Lu Y, et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493-497 pubmed 出版商
  6. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  7. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed 出版商
  8. Yigit B, Halibozek P, Chen S, O Keeffe M, Arnason J, Avigan D, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells. Oncotarget. 2016;7:26346-60 pubmed 出版商
  9. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  10. Jobin C, Cloutier M, Simard C, Néron S. Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral blood. Cytotherapy. 2015;17:1472-84 pubmed 出版商
  11. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed 出版商
  12. Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94 pubmed 出版商